The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial

Relation of Brachial and Digital Measures of Vascular Function in the Community

(2011) Naomi M. Hamburg et al.   HYPERTENSION

Addition of Atrasentan to Renin-Angiotensin System Blockade Reduces Albuminuria in Diabetic Nephropathy

(2011) D. E. Kohan et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Therapeutic potential of endothelin receptor antagonists for chronic proteinuric renal disease in humans

(2010) Matthias Barton   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Long-Term Administration of Endothelin Receptor Antagonist Improves Coronary Endothelial Function in Patients With Early Atherosclerosis

(2010) Martin Reriani et al.   CIRCULATION

Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events

(2010) R. Rubinshtein et al.   EUROPEAN HEART JOURNAL

Avosentan for Overt Diabetic Nephropathy

(2010) J. F.E. Mann et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Assessment of Endothelial Function Using Digital Pulse Amplitude Tonometry

(2009) Naomi M. Hamburg et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Cross-Sectional Relations of Digital Vascular Function to Cardiovascular Risk Factors in the Framingham Heart Study

(2008) Naomi M. Hamburg et al.   CIRCULATION

Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease

(2008) M. Settergren et al.   EUROPEAN HEART JOURNAL

Endothelin-A Receptor Blockade Increases Nutritive Skin Capillary Circulation in Patients with Type 2 Diabetes and Microangiopathy

(2008) Magnus Settergren et al.   JOURNAL OF VASCULAR RESEARCH